Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Lamotrigine use in treatment refractory depression in adolescents

Trial Profile

Lamotrigine use in treatment refractory depression in adolescents

Phase of Trial: Clinical Phase Unknown

Latest Information Update: 22 May 2017

At a glance

  • Drugs Lamotrigine (Primary) ; Fluoxetine; Sertraline
  • Indications Bipolar disorders; Major depressive disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 May 2017 Status changed from suspended to discontinued.
    • 08 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top